Cargando…
Enzymatic Bioconjugation: A Perspective from the Pharmaceutical Industry
[Image: see text] Enzymes have firmly established themselves as bespoke catalysts for small molecule transformations in the pharmaceutical industry, from early research and development stages to large-scale production. In principle, their exquisite selectivity and rate acceleration can also be lever...
Autores principales: | Debon, Aaron, Siirola, Elina, Snajdrova, Radka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207132/ https://www.ncbi.nlm.nih.gov/pubmed/37234110 http://dx.doi.org/10.1021/jacsau.2c00617 |
Ejemplares similares
-
Biocatalysis: Enzymatic Synthesis for Industrial Applications
por: Wu, Shuke, et al.
Publicado: (2020) -
Accelerating Biocatalysis
Discovery with Machine Learning:
A Paradigm Shift in Enzyme Engineering, Discovery, and Design
por: Markus, Braun, et al.
Publicado: (2023) -
Cisplatin bioconjugated enzymatic GNPs amplify the effect of cisplatin with acquiescence
por: Iram, Sana, et al.
Publicado: (2019) -
Looking at CER from the Pharmaceutical Industry Perspective
por: Dubois, Robert W.
Publicado: (2012) -
Accelerated pharmaceutical protein development with integrated cell free expression, purification, and bioconjugation
por: Richardson, Dominique, et al.
Publicado: (2018)